You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 6, March 28, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Cardiovascular System
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Factors Associated With INR Elevation and Bleeding Complications During Warfarin Therapy

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their study, Kucher et al1 reported a brief warning period after the observation of a slightly elevated international normalized ratio (INR) that predicted imminent bleeding in patients undergoing long-term warfarin therapy. However, the authors did not specifically address the causes of INR elevation and whether these causes could have been avoided. The authors point out that, compared with control subjects without bleeding events, patients with warfarin-related hemorrhage were significantly more likely to be receiving 2 or more warfarin "potentiators." Yet interactions between warfarin and other prescription drugs are not the only potential causes of overanticoagulation. Other factors known to alter the response to warfarin include interactions with over-the-counter medications and herbal products, the development of fever or diarrhea, changes in dietary vitamin K intake, underlying comorbid conditions, alcohol intake, and activity level.2 More often than not, however, the specific cause of INR variability is unknown. In a recent study, . . . [Full Text of this Article]


AUTHOR INFORMATION
Ann K. Wittkowsky, PharmD, CACP, FASHP



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

International Normalized Ratio Increase Before Warfarin-Associated Hemorrhage: Brief and Subtle
Nils Kucher, Shannon Connolly, Joshua A. Beckman, Lay Har Cheng, Kanella V. Tsilimingras, John Fanikos, and Samuel Z. Goldhaber
Arch Intern Med. 2004;164(19):2176-2179.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.